Brincidofovir
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| Legal status |
|
| Identifiers | |
| CAS number | 444805-28-1 |
| ATC code | ? |
| PubChem | CID 483477 |
| ChemSpider | 424003 |
| ChEMBL | CHEMBL203321 |
| Synonyms | CMX001; Cidofovir-HDP |
| Chemical data | |
| Formula | C27H52N3O7P |
| Mol. mass | 561.70 g/mol |
On October 6, 2014, Chimerix received an FDA authorization for emergency investigational new drug applications of brincidofovir for the treatment of Ebola virus disease. The drug was administered to the patient in the initial Ebola virus case in the US in 2014.[4][5]
References
- Quenelle, Debra C.; Lampert, Bernhardt; Collins, Deborah J.; Rice, Terri L.; Painter, George R.; Kern, Earl R. (2010). "Efficacy of CMX001 against Herpes Simplex Virus Infections in Mice and Correlations with Drug Distribution Studies". The Journal of Infectious Diseases 202 (10): 1492–9. doi:10.1086/656717. PMC 2957530. PMID 20923374.
- "Brincidofovir (CMX001)". Chimerix.
- Chimerix experimental drug shows promise in fighting Ebola virus. WNCN News, 4 September 2014
- http://www.huffingtonpost.com/2014/10/06/experimental-drug-dallas-ebola-thomas-eric-duncan_n_5941104.html
- http://money.cnn.com/news/newsfeeds/articles/globenewswire/10101305.htm
 |
This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
end quote from:
brincidofovir
No comments:
Post a Comment